Contineum Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | $50.0M | $0.00 | none on file |
| Operating income | $16.1M | −$50.9M | −$68.1M |
| Net income | $22.7M | −$42.3M | −$60.0M |
| Operating cash flow | $19.3M | −$32.8M | −$55.3M |
| Free cash flow | $18.9M | −$33.4M | −$55.5M |
| Cash | $15.5M | $21.9M | $75.6M |
| Shares outstanding | 3.4M | 19.4M | 27.7M |